Cefixime Versus Benzathine Penicillin G in Treatment of Early Syphilis
Key facts
- Who runs it
- Bulovka Hospital
- Where
- Czechia2 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Terminated
- Phase
- Phase 4
- People taking part
- 61 people enrolled
- Started
- 13 Jul 2021
- Ended
- 1 Aug 2024
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Cefixime 400mg
- Benzathine penicillin 2.4 million units
- Record updated
- 2 April 2025
- Why it stopped
- For financial and personnel reasons, patient recruitment was carried out in only one of the planned centers.
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 15 criteriaShow less
Who can take part
- 18 years of age or older
- Non-pregnant, non breastfeeding
- Able to provide informed consent
- Clinically or laboratory-confirmed primary, secondary or early latent syphilis with a positive rapid treponemal test and an RPR/VDRL titer equal to or greater than 1:8
- Non-cephalosporin allergic
- Non-penicillin allergic
- Agree to be occasionally called by study staff to be reminded to take study drug
- Willing to attend follow-up visits
Who cannot take part
- Prior history of syphilis in last two years
- Systemic antibiotic therapy in last two weeks
- Previous enrollment in the study
- Allergy or contraindication to penicillin or cephalosporins (including allergy to cefixime)
- Presenting a situation or condition that would not allow reliable study follow up (For example: frequent travel, alcohol abuse or substance misuse)
- Under 18 years of age
- Pregnancy, breastfeeding
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This study evaluates the efficacy (non-inferiority) and safety of a new antibiotic treatment (cefixime), which has been previously used for single dose therapy of gonorrhoea in many years , in the treatment of early syphilis. Participants will be randomized to one of two study arms and will receive either expirimental regimen (cefixime) or the current standard antibiotic regimen (benzathine penicillin G). New treatment alternatives for syphilis could ensure that people are appropriately treated during periods or in settings of benzathine penicillin G stock out, penicillin allergy, or other intolerance to penicillin injection. This study may also identify an oral regimen for settings in which injections are not feasible.
The 2 groups in the trial
- CefiximeTreatment being tested
cefixime 400 mg taken orally two times a day for 14 consecutive days
Treatment: Cefixime 400mg
- benzathine penicillin GExisting treatment, for comparison
benzathine penicillin G 2.4 MIU single dose intramuscularly
Treatment: Benzathine penicillin 2.4 million units
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Cefixime Versus Benzathine Penicillin G in Treatment of Early Syphilis - a Randomized, Multicentre, Non-inferiority, Open Label Trial
- Record updated
- 2 April 2025